Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AVP-786 vs AVP-923 PK Study in Healthy Volunteers
NCT02336347Phase 1Completed
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization
- Start
- May 2014
- Primary completion
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of deudextromethorphan (2 arms), sponsored by Otsuka Pharmaceutical Development & Commercialization. Primary endpoint: Pharmacokinetics of d6-DM at 8 days. Started May 2014; status: completed.
02
Drugs
deudextromethorphan
Beyond the preview
Go deeper on NCT02336347.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02336347.